Pediatric anesthesia & critical care

Pulmonary Atelectasis After Sedation With Propofol vs Propofol-Ketamine for Magnetic Resonance Imaging in Children: A Randomized Clinical Trial

JAMA Netw OpenPublished Randomised controlled trial

Primary resultResult — go to the resultRelative risk 0.7 95% CI 0.5–0.8

Authors' conclusion

In this randomized clinical trial, the propofol-ketamine combination reduced sedation-induced atelectasis while allowing for faster emergence compared with propofol alone.

Study context

Population
Children aged 3 to 12 years, ASA I to II, undergoing elective magnetic resonance imaging (MRI) under deep sedationanalysed
Participants
107 children
Comparison
Propofol-ketamine vs propofol sedation for MRI
  • Propofoln = 54reference
  • Propofol-ketaminen = 53
Primary endpoint
Incidence of atelectasis assessed by lung ultrasonography
Methodological detailsdouble-masked, single-centre (tertiary referral center)
  • Double-masked
  • Single-centre (tertiary referral center)

Primary result

As reported in the abstract

Relative risk

0.7

95% CI 0.5–0.8

P < 0.001

Events by treatment group

Propofol-ketamine vs Propofol
RR 0.7 (95% CI 0.5–0.8); P < 0.001

Further findings

Median, minutes

OutcomePropofolPropofol-ketamineMedian difference (minutes) (95% CI)P value
Emergence timeFaster emergence with propofol-ketamine25 (IQR 22–27)15 (IQR 9–23)9.0 (6.0–12.0)P < 0.001

MRI interruption due to airway intervention or spontaneous movement

Did not significantly differ between the groups

Safety

Desaturation

Did not significantly differ between the groups

Withdrawal due to adverse effects

No patient withdrawn due to adverse effects

Original publication

Pulmonary Atelectasis After Sedation With Propofol vs Propofol-Ketamine for Magnetic Resonance Imaging in Children: A Randomized Clinical Trial. JAMA Netw Open. Published 1 November 2024. doi:10.1001/jamanetworkopen.2024.33029

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.